<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>OnSight Pathology: A real-time platform-agnostic computational pathology companion for histopathology - Health AI Hub</title>
    <meta name="description" content="OnSight Pathology is a novel, platform-agnostic computer vision software designed to provide real-time AI inferences for histopathology. It overcomes existing b">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>OnSight Pathology: A real-time platform-agnostic computational pathology companion for histopathology</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.04187v1" target="_blank">2512.04187v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-03
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Jinzhen Hu, Kevin Faust, Parsa Babaei Zadeh, Adrienn Bourkas, Shane Eaton, Andrew Young, Anzar Alvi, Dimitrios George Oreopoulos, Ameesha Paliwal, Assem Saleh Alrumeh, Evelyn Rose Kamski-Hennekam, Phedias Diamandis
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.04187v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.04187v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">OnSight Pathology is a novel, platform-agnostic computer vision software designed to provide real-time AI inferences for histopathology. It overcomes existing barriers to AI adoption by operating locally on consumer-grade PCs via continuous screen captures, demonstrating robust utility across various diagnostic tasks and digital slide viewers without complex software integration. This solution aims to enhance diagnostic accuracy and accessibility by delivering secure and cost-effective AI analysis directly to the pathologist's workflow.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This platform significantly impacts medical practice by improving the accuracy and consistency of histological diagnoses, reducing subjectivity, and democratizing access to advanced AI capabilities. It enables more efficient and reliable disease classification, potentially leading to better patient care and broader access to specialized expertise.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>AI-assisted diagnosis and analysis in histopathology; automated classification of tumors and other disease features from digital pathology slides; real-time AI support for pathologists in clinical, intraoperative, and telepathology settings; quality control for diagnostic pathology using AI.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses critical challenges in histopathology: subjectivity, reliance on highly specialized experts, and deployment barriers from proprietary digital pathology solutions.</li>
                    
                    <li>Introduces OnSight Pathology as a platform-agnostic computer vision software that uses continuous screen captures to deliver real-time AI inferences to users reviewing digital slide images.</li>
                    
                    <li>Designed for cost-effective and secure deployment: operates locally on consumer-grade personal computers as a self-contained executable, requiring no complex software integration.</li>
                    
                    <li>Demonstrated utility and robustness across diverse settings, validated using over 2,500 publicly available whole slide images (WSIs) across different slide viewers, and cases from clinical digital pathology setups.</li>
                    
                    <li>Successfully applied to routine histopathological tasks including brain tumor type classification, mitosis detection, and quantification of immunohistochemical stains.</li>
                    
                    <li>Features a built-in multi-modal chat assistant for verifiable image descriptions, offering quality control, and is compatible with live microscope camera feeds, including smartphones.</li>
                    
                    <li>Highlights the potential to deliver real-time AI inferences across a broad range of pathology pipelines, effectively removing key technical and financial barriers to AI tool adoption in histopathology.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>OnSight Pathology operates as a self-contained computer vision software that provides real-time AI inferences by continuously capturing the user's screen. This enables it to work with any digital slide viewer or live microscope feed. It was demonstrated on over 2,500 publicly available whole slide images across various viewers and clinical cases. The software performed tasks such as classifying brain tumor types, detecting mitosis, and quantifying immunohistochemical stains, leveraging underlying AI models.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The study successfully demonstrated OnSight Pathology's robust utility in providing real-time AI inferences for routine histopathological tasks across diverse digital pathology platforms and even live microscope feeds. Its platform-agnostic and locally-operating design effectively overcomes common barriers to AI adoption, enabling cost-effective and secure deployment in both research and clinical environments.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>OnSight Pathology holds significant potential to revolutionize clinical pathology by enhancing diagnostic precision, reducing inter-observer variability, and speeding up turnaround times. It can provide immediate AI assistance during complex diagnoses, facilitate telepathology consultations in remote areas, and improve intraoperative decision-making by integrating AI directly into various existing pathology workflows.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly mention any specific limitations of the OnSight Pathology platform.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The authors suggest expanding deployment to more analog, inter-operative, and telepathology settings. They also highlight the potential for leveraging its compatibility with live microscope camera feeds, including from personal smartphones, to broaden its application in various diagnostic contexts.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Histopathology</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Neuropathology</span>
                    
                    <span class="tag">Diagnostic Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Computational Pathology</span>
                    
                    <span class="tag tag-keyword">Digital Pathology</span>
                    
                    <span class="tag tag-keyword">Artificial Intelligence</span>
                    
                    <span class="tag tag-keyword">Histopathology</span>
                    
                    <span class="tag tag-keyword">Real-time AI</span>
                    
                    <span class="tag tag-keyword">Platform-agnostic</span>
                    
                    <span class="tag tag-keyword">Whole Slide Imaging</span>
                    
                    <span class="tag tag-keyword">Telepathology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">The microscopic examination of surgical tissue remains a cornerstone of disease classification but relies on subjective interpretations and access to highly specialized experts, which can compromise accuracy and clinical care. While emerging breakthroughs in artificial intelligence (AI) offer promise for automated histological analysis, the growing number of proprietary digital pathology solutions has created barriers to real-world deployment. To address these challenges, we introduce OnSight Pathology, a platform-agnostic computer vision software that uses continuous custom screen captures to provide real-time AI inferences to users as they review digital slide images. Accessible as a single, self-contained executable file (https://onsightpathology.github.io/ ), OnSight Pathology operates locally on consumer-grade personal computers without complex software integration, enabling cost-effective and secure deployment in research and clinical workflows. Here we demonstrate the utility of OnSight Pathology using over 2,500 publicly available whole slide images across different slide viewers, as well as cases from our clinical digital pathology setup. The software's robustness is highlighted across routine histopathological tasks, including the classification of common brain tumor types, mitosis detection, and the quantification of immunohistochemical stains. A built-in multi-modal chat assistant provides verifiable descriptions of images, free of rigid class labels, for added quality control. Lastly, we show compatibility with live microscope camera feeds, including from personal smartphones, offering potential for deployment in more analog, inter-operative, and telepathology settings. Together, we highlight how OnSight Pathology can deliver real-time AI inferences across a broad range of pathology pipelines, removing key barriers to the adoption of AI tools in histopathology.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>